Cited by 83Neurotransmitter Receptor Influence on BehaviorNeuroethics, Human Enhancement, Biomedical InnovationsNeural and Behavioral Psychology Studies

Modulatory Effects of Modafinil on Neural Circuits Regulating Emotion and Cognition

Open access
Rasetti, Roberta, Mattay, Venkata S, Stankevich, Beth, Skjei, Kelsey, Blasi, Giuseppe, Sambataro, Fabio, Arrillaga-Romany, Isabel C, Goldberg, Terry E +3 more·2010·Neuropsychopharmacology

Abstract

Modafinil differs from other arousal-enhancing agents in chemical structure, neurochemical profile, and behavioral effects. Most functional neuroimaging studies to date examined the effect of modafinil only on information processing underlying executive cognition, but cognitive enhancers in general have been shown to have pronounced effects on emotional behavior, too. We examined the effect of modafinil on neural circuits underlying affective processing and cognitive functions. Healthy volunteers were enrolled in this double-blinded placebo-controlled trial (100 mg/day for 7 days). They underwent BOLD fMRI while performing an emotion information-processing task that activates the amygdala and two prefrontally dependent cognitive tasks-a working memory (WM) task and a variable attentional control (VAC) task. A clinical assessment that included measurement of blood pressure, heart rate, the Hamilton anxiety scale, and the profile of mood state (POMS) questionnaire was also performed on each test day. BOLD fMRI revealed significantly decreased amygdala reactivity to fearful stimuli on modafinil compared with the placebo condition. During executive cognition tasks, a WM task and a VAC task, modafinil reduced BOLD signal in the prefrontal cortex and anterior cingulate. Although not statistically significant, there were trends for reduced anxiety, for decreased fatigue-inertia and increased vigor-activity, as well as decreased anger-hostility on modafinil. Modafinil in low doses has a unique physiologic profile compared with stimulant drugs: it enhances the efficiency of prefrontal cortical cognitive information processing, while dampening reactivity to threatening stimuli in the amygdala, a brain region implicated in anxiety.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/npp.2010.83

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In healthy adults, modafinil decreases amygdala activation during the viewing of fearful stimuli and boosts prefrontal cortical activation during executive functions.

    “In healthy adults, modafinil decreases amygdala activation during the viewing of fearful stimuli and boosts prefrontal cortical activation during executive functions (132).”

    From Emotion Dysregulation in Attention Deficit Hyperactivity Disorder (2014) · cites this paper as [132]

    The Results (Neuroimaging Data) support the claim that modafinil lowered amygdala activation during processing of fearful and angry faces. But the Abstract and Discussion report reduced, not boosted, prefrontal activation during executive-cognition tasks. The second half of the attributed claim reverses the paper’s finding. (LLM, conf=0.92)

    Checked by a reasoning model — may be wrong.

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 45

  1. Angrist BM Gershon S The phenomenology of experimentally induced amphetamine psychosis—preliminary observations Biol Psychiatry 1970 2 95 107 5459137
  2. Apud JA Mattay V Chen J Kolachana BS Callicott JH Rasetti R Tolcapone improves cognition and cortical information processing in normal human subjects Neuropsychopharmacology 2007 32 1011 1020 17063156
  3. Becker PM Schwartz JR Feldman NT Hughes RJ Effect of modafinil on fatigue, mood, and health-related quality of life in patients with narcolepsy Psychopharmacology (Berl) 2004 171 133 139 14647965
  4. Blasi G Mattay VS Bertolino A Elvevåg B Callicott JH Das S Effect of catechol-o-methyltransferase val158met genotype on attentional control J Neurosci 2005 25 5038 5045 15901785 PMC6724859
  5. Brennan AR Arnsten AF Neuronal mechanisms underlying attention deficit hyperactivity disorder: the influence of arousal on prefrontal cortical function Ann NY Acad Sci 2008 1129 236 245 18591484 PMC2863119
  6. Broughton RJ Fleming JA George CF Hill JD Kryger MH Moldofsky H Randomized, double-blind, placebo-controlled crossover trial of modafinil in the treatment of excessive daytime sleepiness in narcolepsy Neurology 1997 49 444 451 9270575
  7. Callicott JH Egan MF Mattay VS Bertolino A Bone AD Verchinksi B Abnormal fMRI response of the dorsolateral prefrontal cortex in cognitively intact siblings of patients with schizophrenia Am J Psychiatry 2003 160 709 719 12668360
  8. Cools R Robbins TW Chemistry of the adaptive mind Philos Transact A Math Phys Eng Sci 2004 362 2871 2888 15539374
  9. Cools R Stefanova E Barker RA Robbins TW Owen AM Dopaminergic modulation of high-level cognition in Parkinson’s disease: the role of the prefrontal cortex revealed by PET Brain 2002 125 584 594 11872615
  10. Deroche-Gamonet V Darnaudéry M Bruins-Slot L Piat F Le Moal M Piazza PV Study of the addictive potential of modafinil in naive and cocaine-experienced rats Psychopharmacology (Berl) 2002 161 387 395 12073166
  11. Ekman P Friesen WV Pictures of Facial Affect 1976 Palo Alto, CA Consulting Psychologist Press
  12. Ellinwood EH Jr Sudilovsky A Nelson LM Evolving behavior in the clinical and experimental amphetamine (model) psychosis Am J Psychiatry 1973 130 1088 1093 4353974
  13. Friston KJ Zarahn E Josephs O Henson RN Dale AM Stochastic designs in event-related fMRI Neuroimage 1999 10 607 619 10547338
  14. Gibbs SE D’Esposito M A functional MRI study of the effects of bromocriptine, a dopamine receptor agonist, on component processes of working memory Psychopharmacology (Berl) 2005 180 644 653 16001111
  15. Gorman SH Determination of modafinil, modafinil acid and modafinil sulfone in human plasma utilizing liquid-liquid extraction and high-performance liquid chromatography J Chromatogr B Analyt Technol Biomed Life Sci 2002 767 269 276 11885856
  16. Hall RC Popkin MK Beresford TP Hall AK Amphetamine psychosis: clinical presentations and differential diagnosis Psychiatr Med 1988 6 73 79 3399693
  17. Hamilton M The assessment of anxiety states by rating Br J Med Psychol 1959 32 50 55 13638508
  18. Hariri AR Mattay VS Tessitore A Fera F Smith WG Weinberger DR Dextroamphetamine modulates the response of the human amygdala Neuropsychopharmacology 2002 27 1036 1040 12464460
  19. Harmer CJ Mackay CE Reid CB Cowen PJ Goodwin GM Antidepressant drug treatment modifies the neural processing of nonconscious threat cues Biol Psychiatry 2006 59 816 820 16460693
  20. Hermant JF Rambert FA Duteil J Awakening properties of modafinil: effect on nocturnal activity in monkeys (Macaca mulatta) after acute and repeated administration Psychopharmacology (Berl) 1991 103 28 32 1672457
  21. Hunter MD Ganesan V Wilkinson ID Spence SA Impact of modafinil on prefrontal executive function in schizophrenia Am J Psychiatry 2006 163 2184 2186 17151173
  22. Jr JL Regan C Stump G Tannenbaum P Stevens J Bone A Hemodynamic and cardiac neurotransmitter- releasing effects in conscious dogs of attention- and wake-promoting agents: a comparison of d-amphetamine, atomoxetine, modafinil, and a novel quinazolinone H3 inverse agonist J Cardiovasc Pharmacol 2009 53 52 59 19129736
  23. MacDonald JR Hill JD Tarnopolsky MA Modafinil reduces excessive somnolence and enhances mood in patients with myotonic dystrophy Neurology 2002 59 1876 1880 12499477
  24. Madras BK Xie Z Lin Z Jassen A Panas H Lynch L Modafinil occupies dopamine and norepinephrine transporters in vivo and modulates the transporters and trace amine activity in vitro J Pharmacol Exp Ther 2006 319 561 569 16885432
  25. Makris AP Rush CR Frederich RC Kelly TH Wake-promoting agents with different mechanisms of action: comparison of effects of modafinil and amphetamine on food intake and cardiovascular activity Appetite 2004 42 185 195 15010183
  26. Mattay VS Goldberg TE Fera F Hariri AR Tessitore A Egan MF Catechol o-methyltransferase val158-met genotype and individual variation in the brain response to amphetamine Proc Natl Acad Sci USA 2003 100 6186 6191 12716966 PMC156347
  27. Mattay VS Tessitore A Callicott JH Bertolino A Goldberg TE Chase TN Dopaminergic modulation of cortical function in patients with Parkinson’s disease Ann Neurol 2002 51 156 164 11835371
  28. Minzenberg MJ Carter CS Modafinil: a review of neurochemical actions and effects on cognition Neuropsychopharmacology 2008 33 1477 1502 17712350
  29. Minzenberg MJ Watrous AJ Yoon JH Ursu S Carter CS Modafinil shifts human locus coeruleus to low-tonic, high-phasic activity during functional MRI Science 2008 322 1700 1702 19074351
  30. Pezawas L Meyer-Lindenberg A Drabant EM Verchinski BA Munoz KE Kolachana BS 5-HTTLPR polymorphism impacts human cingulate-amygdala interactions: a genetic susceptibility mechanism for depression Nat Neurosci 2005 8 828 834 15880108
  31. Qu WM Huang ZL Xu XH Matsumoto N Urade Y Dopaminergic D1 and D2 receptors are essential for the arousal effect of modafinil J Neurosci 2008 28 8462 8469 18716204 PMC6671058
  32. Robertson P Jr Hellriegel ET Clinical pharmacokinetic profile of modafinil Clin Pharmacokinet 2003 42 123 137 12537513
  33. Saletu M Anderer P Semlitsch HV Saletu-Zyhlarz GM Mandl M Zeitlhofer J Low-resolution brain electromagnetic tomography (LORETA) identifies brain regions linked to psychometric performance under modafinil in narcolepsy Psychiatry Res 2007 154 69 84 17187965
  34. Samuels ER Hou RH Langley RW Szabadi E Bradshaw CM Comparison of pramipexole and modafinil on arousal, autonomic, and endocrine functions in healthy volunteers J Psychopharmacol 2006 20 756 770 16401653
  35. Simon P Panissaud C Costentin J The stimulant effect of modafinil on wakefulness is not associated with an increase in anxiety in mice. A comparison with dexamphetamine Psychopharmacology (Berl) 1994 114 597 600 7855221
  36. Spence SA Green RD Wilkinson ID Hunter MD Modafinil modulates anterior cingulate function in chronic schizophrenia Br J Psychiatry 2005 187 55 61 15994572
  37. Tan HY Callicott JH Weinberger DR Dysfunctional and compensatory prefrontal cortical systems, genes and the pathogenesis of schizophrenia Cereb Cortex 2007 17 Suppl 1 i171 i181 17726000
  38. Taneja I Haman K Shelton RC Robertson D A randomized, double-blind, crossover trial of modafinil on mood J Clin Psychopharmacol 2007 27 76 79 17224718
  39. Thomas RJ Kwong K Modafinil activates cortical and subcortical sites in the sleep-deprived state Sleep 2006 29 1471 1481 17162995
  40. Turner DC Robbins TW Clark L Aron AR Dowson J Sahakian BJ Cognitive enhancing effects of modafinil in healthy volunteers Psychopharmacology (Berl) 2003 165 260 269 12417966
  41. van Vliet SA Jongsma MJ Vanwersch RA Olivier B Philippens IH Behavioral effects of modafinil in marmoset monkeys Psychopharmacology (Berl) 2006 185 433 440 16550386
  42. Volkow ND Fowler JS Logan J Alexoff D Zhu W Telang F Effects of modafinil on dopamine and dopamine transporters in the male human brain: clinical implications JAMA 2009 301 1148 1154 19293415 PMC2696807
  43. Wesensten NJ Effects of modafinil on cognitive performance and alertness during sleep deprivation Curr Pharm Des 2006 12 2457 2471 16842170
  44. Winder-Rhodes S Chamberlain S Idris M Robbins T Sahakian B Müller U Effects of modafinil and prazosin on cognitive and physiological functions in healthy volunteers J Psychopharmacol 2010 print copy in press (originally published online 3 Jun 2009, at http://jop.sagepub.com/cgi/rapidpdf/0269881109105899v1) 19493958
  45. Zifko UA Rupp M Schwarz S Zipko HT Maida EM Modafinil in treatment of fatigue in multiple sclerosis. Results of an open-label study J Neurol 2002 249 983 987 12195441

Cited by

Sorted by citations

Authors
Rasetti, R., Mattay, V. S., Stankevich, B., Skjei, K., Blasi, G., Sambataro, F., Arrillaga-Romany, I. C., Goldberg, T. E., Callicott, J. H., Apud, J. A., & Weinberger, D. R.
Affiliations
National Institutes of Health (US)
Corresponding author
Weinberger, Daniel R
Venue
Neuropsychopharmacology
Published
2010-06-16
Volume
35
Issue
10
Pages
2101-2109
ISSN
  • 0893-133X (ISSN-L)
  • 1740-634X
OpenAlex
W2093959215
Cited by
83
References
5
Citations by year
2025: 5 · 2024: 1 · 2023: 5 · 2021: 2 · 2020: 5 · 2019: 3 · 2018: 3 · 2017: 13 · 2016: 2 · 2015: 9 · 2014: 6 · 2013: 13 · 2012: 8
FWCI
3.88
Type
journal article
Language
en
Open access
Locations
  • Neuropsychopharmacology (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • Institutional Research Information System (University of Udine) (submittedVersion)
  • CINECA IRIS Institutional Research Information System (University of Bari Aldo Moro) (submittedVersion)
  • Padua Research Archive (University of Padova) (submittedVersion)
Funders
  • National Institutes of Health
  • National Institute of Mental Health (Z01MH002905)
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Neuroethics, Human Enhancement, Biomedical Innovations
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Neural and Behavioral Psychology Studies
Keywords
modafinil, nootropic drugs, amygdala reactivity, fear processing, working memory, attentional control, prefrontal cortex, anterior cingulate cortex, anxiety, mood, arousal, executive function, neural circuits
MeSH terms
Modafinil, Adult, Benzhydryl Compounds, Brain, Brain Mapping, Cognition, Dose-Response Relationship, Drug, Double-Blind Method, Emotions, Female, Humans, Image Processing, Computer-Assisted, Magnetic Resonance Imaging, Male, Neuropsychological Tests, Oxygen, Statistics as Topic, Cross-Over Studies, Neuroprotective Agents

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review